Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell SubsetsRyan D. Michalek, Jeffrey C. Rathmell|The Journal of Immunology|2011Cited by 2k
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent PathwaysSarah R. Jacobs, Jeffrey C. Rathmell|The Journal of Immunology|2008Cited by 836
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A. Gerriets, Jeffrey C. Rathmell, Rigel J. Kishton et al.|Journal of Clinical Investigation|2014Cited by 717
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J. Siska, Jeffrey C. Rathmell|JCI Insight|2017Cited by 380
Immunometabolism: From basic mechanisms to translationLiza Makowski, Jeffrey C. Rathmell|Immunological Reviews|2020Cited by 372